Clinical Trial Update: A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating the iron chelator deferiprone in Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Deferiprone (deferiprone)

Snippet

Sponsor: Imperial College London | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-06-16